| Identification | Back Directory | [Name]
DOTA-NAPamide trifluoroacetate | [CAS]
935886-72-9 | [Synonyms]
DOTA-NAPamide trifluoroacetate L-Lysinamide, N-acetyl-L-norleucyl-L-α-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophylglycyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]- | [Molecular Formula]
C68H100N20O18 | [MOL File]
935886-72-9.mol | [Molecular Weight]
1485.67 |
| Hazard Information | Back Directory | [Uses]
DOTA-NAPamide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1]. |
|
|